FilingSEC EDGAR6-K
Clearmind Medicine Announces Patent Publication in Japan for Neurological Movement Disorder Treatment
· SEC accepted
Stagepatent
Filing content
Clearmind Medicine announced the publication of a patent application in Japan covering 3-MMC-based treatments for dyskinesia, including combinations with PEA.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…